<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Illumina  Company Newsfeed</title>
<link>http://www.advfn.com/nasdaq/rss.asp?symbol=ILMN</link>
<description>Illumina  Company Newsfeed</description>
<language>en</language>
<pubDate>Tue, 23 Apr 2013 07:20:10 EDT</pubDate>
<lastBuildDate>Tue, 23 Apr 2013 07:20:10 EDT</lastBuildDate>
  
  
 <item>
 <title>U.S. Stock Futures Slip; China, Germany Growth Fears</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57284308&amp;headline=u-s-stock-futures-slip-china-germany-growth-fears</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57284308&amp;headline=u-s-stock-futures-slip-china-germany-growth-fears</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; U.S. stock index futures drifted lower Tuesday, undercut by global growth fears in the wake of disappointing Chinese and German data as investors await fresh U.S. housing figures and another heavy round of corporate earnings. &#60;/p&#62;
&#60;p&#62; Apple Inc. (AAPL) reports after the closing...</description>
 <pubDate>Tue, 23 Apr 2013 07:20:10 EDT</pubDate>
 </item>

 <item>
 <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57283773&amp;headline=u-s-hot-stock-futures-hot-stocks-to-watch</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57283773&amp;headline=u-s-hot-stock-futures-hot-stocks-to-watch</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Among the companies with shares expected to actively trade in Tuesday's session are are Netflix Inc. (NFLX), Rent-A-Center Inc. (RCII), Veeco Instruments Inc. (VECO) &#60;/p&#62;
&#60;p&#62; Netflix swung to a first-quarter profit as the movie-subscription company continued to add Internet...</description>
 <pubDate>Tue, 23 Apr 2013 06:56:12 EDT</pubDate>
 </item>

 <item>
 <title>Thermo Fisher Enters Field of Gene Sequencing</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57177364&amp;headline=thermo-fisher-enters-field-of-gene-sequencing</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57177364&amp;headline=thermo-fisher-enters-field-of-gene-sequencing</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; With its $13.6 billion acquisition of Life Technologies Corp. (LIFE), Thermo Fisher Scientific Inc. (TMO) is expected to enter the competitive but growing market for genetic sequencing--the one area of laboratory equipment it has shied away from while growing into the world's...</description>
 <pubDate>Mon, 15 Apr 2013 17:40:09 EDT</pubDate>
 </item>

 <item>
 <title>Thermo Fisher Enters Uncertain Field of Gene Sequencing With...</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57177060&amp;headline=thermo-fisher-enters-uncertain-field-of-gene-sequencing-with</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57177060&amp;headline=thermo-fisher-enters-uncertain-field-of-gene-sequencing-with</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Joseph Walker &#60;/pre&#62;
&#60;p&#62; With its $13.6 billion acquisition of Life Technologies Corp. (LIFE), Thermo Fisher Scientific Inc. (TMO) is expected to enter the competitive but growing market for genetic sequencing--the one area of laboratory equipment it has shied away from...</description>
 <pubDate>Mon, 15 Apr 2013 17:25:19 EDT</pubDate>
 </item>

 <item>
 <title>Life Technologies Showing New Life Amid Takeover Talk</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57110066&amp;headline=life-technologies-showing-new-life-amid-takeover-talk</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=57110066&amp;headline=life-technologies-showing-new-life-amid-takeover-talk</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Joseph Walker &#60;/pre&#62;
&#60;p&#62; Acquisition talks have given new momentum to Life Technologies Corp.'s (LIFE) shares after years of shareholder complaints about the company's leadership and its stock being undervalued. &#60;/p&#62;
&#60;p&#62; For more than a decade, the Carlsbad, Calif., company...</description>
 <pubDate>Wed, 10 Apr 2013 15:48:08 EDT</pubDate>
 </item>

 <item>
 <title>Illumina Off 7.8% Premarket After Roche Talks Down Deal</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=55727498&amp;headline=illumina-off-7-8-premarket-after-roche-talks-down-deal</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=55727498&amp;headline=illumina-off-7-8-premarket-after-roche-talks-down-deal</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Illumina Inc. (ILMN) fell back 7.8% in premarket trading Monday after Roche Holding (RHHBY) Chairman Franz Humer said in an interview that the company doesn't plan to buy the gene sequencing specialist. &#60;/p&#62;
&#60;p&#62; &#34;Illumina is definitely off the table,&#34; Humer said in an interview...</description>
 <pubDate>Mon, 07 Jan 2013 09:10:14 EST</pubDate>
 </item>

 <item>
 <title>Roche Says Illumina Bid is 'Off the Table'</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=55718882&amp;headline=roche-says-illumina-bid-is-off-the-table</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=55718882&amp;headline=roche-says-illumina-bid-is-off-the-table</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; ZURICH--Swiss drug maker Roche Holding AG (ROG.VX) is not considering another takeover bid for U.S. gene-sequencing company Illumina (ILMN), Chairman Franz Humer was quoted as saying Sunday in a newspaper interview. &#60;/p&#62;
&#60;p&#62; &#34;Illumina is definitely off the table. Our counterpart...</description>
 <pubDate>Mon, 07 Jan 2013 00:20:18 EST</pubDate>
 </item>

 <item>
 <title>Roche Chairman: Illumina Bid is 'Off the Table' - Report</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=55716368&amp;headline=roche-chairman-illumina-bid-is-off-the-table-report</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=55716368&amp;headline=roche-chairman-illumina-bid-is-off-the-table-report</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; ZURICH--Swiss drug maker Roche Holding AG (ROG.VX) is not considering another takeover bid for U.S. gene-sequencing company Illumina (ILMN), Chairman Franz Humer was quoted as saying Sunday in a newspaper interview. &#60;/p&#62;
&#60;p&#62; &#34;Illumina is definitely off the table. Our counterpart...</description>
 <pubDate>Sun, 06 Jan 2013 06:48:31 EST</pubDate>
 </item>

 <item>
 <title>Roche CEO Rules Out Further Big Job Cuts, Illumina Talks -Report</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52715750&amp;headline=roche-ceo-rules-out-further-big-job-cuts-illumina-talks-report</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52715750&amp;headline=roche-ceo-rules-out-further-big-job-cuts-illumina-talks-report</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; ZURICH--The chief executive of Swiss pharmaceuticals company Roche Holding AG (ROG.VX) said it has ruled out another major cost-savings program and further talks with U.S. gene testing company Illumina Inc.(ILMN) &#60;/p&#62;
&#60;p&#62; The Basel company has almost completed a reduction of...</description>
 <pubDate>Sun, 10 Jun 2012 09:12:13 EDT</pubDate>
 </item>

 <item>
 <title>Roche Pursuing Other Opportunities After Failed Illumina Bid...</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52271925&amp;headline=roche-pursuing-other-opportunities-after-failed-illumina-bid</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52271925&amp;headline=roche-pursuing-other-opportunities-after-failed-illumina-bid</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Alex MacDonald &#60;/p&#62;
&#60;p&#62; Of DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; ST. GALLEN, Switzerland -(Dow Jones)- Swiss Drug maker Roche Holding AG (ROG.VX) will pursue other opportunities to grow its business following the failure of its bid for U.S. diagnostics company Illumina Inc. (ILMN...</description>
 <pubDate>Thu, 03 May 2012 11:24:59 EDT</pubDate>
 </item>

 <item>
 <title>Pharma M&amp;A Surge Spurred By Necessity And Opportunity</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52187451&amp;headline=pharma-m-a-surge-spurred-by-necessity-and-opportunity</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52187451&amp;headline=pharma-m-a-surge-spurred-by-necessity-and-opportunity</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Sten Stovall &#60;/p&#62;
&#60;p&#62; Of DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; LONDON -(Dow Jones)- The sudden willingness of European drug companies to launch hostile takeover bids -- underscored by numerous bids this month -- underlines the depth of the sector's problems and its need to find new...</description>
 <pubDate>Fri, 27 Apr 2012 10:54:37 EDT</pubDate>
 </item>

 <item>
 <title>Roche To Return Tendered Illumina Shares To Shareholders</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52103624&amp;headline=roche-to-return-tendered-illumina-shares-to-shareholders</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52103624&amp;headline=roche-to-return-tendered-illumina-shares-to-shareholders</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Marta Falconi &#60;/p&#62;
&#60;p&#62; Of DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; ZURICH -(Dow Jones)- Roche Holding AG (ROG.VX) will return all tendered Illumina Inc. (ILMN) shares to the company's shareholders following the Swiss drug maker decision to drop its bid to buy the U.S. diagnostics company...</description>
 <pubDate>Mon, 23 Apr 2012 05:47:03 EDT</pubDate>
 </item>

 <item>
 <title>DEALWATCH: Battle May Be Over, But War For Illumina Could Resume</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52054708&amp;headline=dealwatch-battle-may-be-over-but-war-for-illumina-could-resume</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52054708&amp;headline=dealwatch-battle-may-be-over-but-war-for-illumina-could-resume</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jessica Hodgson and Marietta Cauchi Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; LONDON -(Dow Jones)- Despite deciding not to extend beyond Friday a $6.5 billion offer for U.S. diagnostics firm Illumina Inc. (ILMN)--effectively withdrawing from its bid to buy the gene sequencing firm--Roche...</description>
 <pubDate>Wed, 18 Apr 2012 12:49:01 EDT</pubDate>
 </item>

 <item>
 <title>Roche Doesn't Plan To Extend Bid For Illumina</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52051440&amp;headline=roche-doesnt-plan-to-extend-bid-for-illumina</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=52051440&amp;headline=roche-doesnt-plan-to-extend-bid-for-illumina</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; Roche Holding AG (ROG.VX) said it doesn't plan to extend its unsolicited takeover bid worth more than $6.5 billion for Illumina Inc. (ILMN) past Friday's deadline, citing preliminary estimates indicating that the incumbents on the U.S. gene-sequencing...</description>
 <pubDate>Wed, 18 Apr 2012 09:55:20 EDT</pubDate>
 </item>

 <item>
 <title>Roche Sees No Reason To Raise Illumina Offer</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51982908&amp;headline=roche-sees-no-reason-to-raise-illumina-offer</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51982908&amp;headline=roche-sees-no-reason-to-raise-illumina-offer</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; ZURICH -(Dow Jones)- Swiss pharmaceutical giant Roche Holding AG (ROG.VX) Thursday said it sees &#34;no reason whatsoever&#34; to increase its offer for Illumina Inc. (ILMN) without entering talks with management at the U.S. gene-sequencing company. &#60;/p&#62;
&#60;p&#62; &#34;Our offer of $51 is a full...</description>
 <pubDate>Thu, 12 Apr 2012 10:46:37 EDT</pubDate>
 </item>

 <item>
 <title>CORRECT: Roche Steps Up Courtship In Illumina Bid</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51982115&amp;headline=correct-roche-steps-up-courtship-in-illumina-bid</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51982115&amp;headline=correct-roche-steps-up-courtship-in-illumina-bid</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; (&#34;3rd UPDATE: Roche Steps Up Courtship In Illumina Bid,&#34; at 1216 GMT, incorrectly attributed statements on Avastin peak sales to Roche's CFO, instead of its pharma division's chief operating officer. Also, Roche has so far not given a time frame for the sales peak. The correct...</description>
 <pubDate>Thu, 12 Apr 2012 10:06:55 EDT</pubDate>
 </item>

 <item>
 <title>Roche Criticizes Illumina's Apple Comparison</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51972461&amp;headline=roche-criticizes-illuminas-apple-comparison</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51972461&amp;headline=roche-criticizes-illuminas-apple-comparison</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; Swiss drug maker Roche Holding AG (ROG.VX, RHHBY) again urged Illumina Inc. (ILMN) shareholders to vote for its slate of board candidates and criticized the U.S. gene-sequencing company for comparing itself to Apple Inc. (AAPL), in Roche's latest...</description>
 <pubDate>Wed, 11 Apr 2012 19:24:11 EDT</pubDate>
 </item>

 <item>
 <title>Third Proxy Firm Sides With Illumina In Roche Fight</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51950348&amp;headline=third-proxy-firm-sides-with-illumina-in-roche-fight</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51950348&amp;headline=third-proxy-firm-sides-with-illumina-in-roche-fight</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; Illumina Inc. (ILMN) said a third proxy-advisory firm, Glass Lewis, is recommending that the U.S. gene-sequencing company's shareholders vote against Swiss drug maker Roche Holding AG's (ROG.VX, RHHBY) slate of board candidates as Illumina continues...</description>
 <pubDate>Tue, 10 Apr 2012 10:23:28 EDT</pubDate>
 </item>

 <item>
 <title>Two Proxy Advisory Firms Side With Illumina In Roche Fight</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51930231&amp;headline=two-proxy-advisory-firms-side-with-illumina-in-roche-fight</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51930231&amp;headline=two-proxy-advisory-firms-side-with-illumina-in-roche-fight</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; Two proxy advisory firms have recommended Illumina Inc. (ILMN) shareholders vote against Swiss drug maker Roche Holding AG's (ROG.VX, RHHBY) nominees to Illumina's board, calling its takeover offer inadequate. &#60;/p&#62;
&#60;p&#62; The proxy advisor reports comes...</description>
 <pubDate>Fri, 06 Apr 2012 14:33:24 EDT</pubDate>
 </item>

 <item>
 <title>Roche Sends Second Letter To Illumina Shareholders</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51892065&amp;headline=roche-sends-second-letter-to-illumina-shareholders</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=ILMN&amp;article=51892065&amp;headline=roche-sends-second-letter-to-illumina-shareholders</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; ZURICH -(Dow Jones)- Roche Holding Holding AG (ROG.VX) Wednesday sent a second letter to shareholders of takeover target Illumina Inc. (NASDAQ: ILMN) urging them to tender their shares into Roche's increased offer and vote for Roche's independent director nominees at the U.S...</description>
 <pubDate>Wed, 04 Apr 2012 01:43:07 EDT</pubDate>
 </item>

</channel>
</rss>